INTRODUCTION
Bacterial artificial chromosomes (BACs) can stably maintain large segments of foreign DNA (approximately 150 kb) and are thus powerful tools for generating long-range physical maps and for sequencing whole genomes. At the beginning of the postgenome sequencing era, BAC systems have become an equally powerful tool for comprehensive functional genomics. For example, BACs have been used as expression systems that contain large introns and exons (1) , and modified BAC clones have been used to introduce lengthy homologous DNA segments into mouse embryonic stem (ES) cells (2) . For the BAC system to be used effectively in all aspects of functional genomics and not only for genome sequencing, it is important to be able to freely manipulate and modify BAC clones containing large DNA inserts. To date, traditional restriction enzyme-ligation methods have been used to prepare targeting vectors for generating knockout mice. It is very difficult, however, to insert suitable marker genes, such as neo (neomycin) and tk (thymidine kinase), into large DNA segments contained within these clones using traditional methods because appropriate restriction enzyme site(s) are not always located in suitable places within the BAC clone. Thus, with traditional restriction enzyme methods, the location and size of the deletion within the targeted gene as well as the correct positioning of a translational frame fused to a reporter gene often depend on and are limited by the presence and position of restriction enzyme sites. Because constructing conditional knockout and knockin mice will increasingly necessitate the construction of more complicated targeting vectors (3), researchers will need a method that allows them to freely modify DNA segments within BAC clones. The Red recombination system promises to be a useful tool in this regard because specific sites within this system can be readily modified with ease and accuracy.
Only three genes are required to carry out recombination using the Red system (4) . The exo gene encodes the Redα protein, a 5′ to 3′ exonuclease that acts on the 5′ ends of a linear double-stranded DNA (dsDNA) fragment to produce 3′ single-stranded DNA (ssDNA) overhangs. The bet gene encodes a pairing protein (Redβ) that binds to the 3′ ssDNA overhangs created by the Redα protein and promotes annealing. The recombination function of Redα and Redβ proteins are further assisted by the λ-encoded Gam protein, which inhibits the RecBCD exonuclease activity of Escherichia coli, thus preventing the degradation of linear DNA fragments. Red-mediated homologous recombination occurs via a short, approximately 50-bp long homologous region shared by the two molecules that are to be recombined. Because the sequence of these homologous regions can be chosen freely, any part of the target molecule can be specifically altered.
Some have attempted to increase the rate of the Red recombination system using short (40-60 bp) homologous DNAs, but not long homologous arms (200-500 bp) (5) . One group (6) (7) (8) 
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inducible promoter, which directs the expression of Red proteins, to a strong promoter that mediates continuous expression of bet and gam. They also employed an expression system based on low copy number plasmids depending on the oriR101. Another group (9,10) integrated a defective λ prophage into the E. coli chromosome. In the defective prophage system, the expression of exo, bet, and gam genes is directed by the strong λ P L promoter, which itself is under the control of the temperaturesensitive λ cI857 repressor. At 32°C, the expression of exo, bet, and gam is undetectable. However, by shifting the culture temperature to 42°C for 15 min, the expression of Redα, Redβ, and Gam is induced to very high levels. When the Red system is used to modify BAC clones, it is convenient to use plasmids derived from pBR322 of ColE1 origin because they are compatible with BAC vectors of F factor origin and because they can maintain high copy numbers and be handled easily and conveniently. When used in conjunction with high copy number plasmids, however, the recombination efficiency of the Red system with PCR-generated substrates is generally low (4) . One possible reason is that the inhibition of RecBCD by Gam causes the formation of plasmid multimers, which decreases the frequency of recombination.
Although the Red recombination system is very useful for the flexible modification of BAC clones using only short 40-60 bp homologous fragments, one weakness of this system is that its recombination efficiency is still too low for routine use by nonspecialists. To further increase the efficiency of Red recombination, we propose a qualitatively different method from the previous approaches of changing promoters and copy number of expression units. To achieve our goal, it is necessary to examine in detail the factors that affect recombination efficiency. Thus, in the current study, we analyzed factors that influence the efficiency of Red recombination. We identified mutants of Redα and Redβ that improved the efficiency of Red recombination. We also describe the importance of the 5′ untranslated region (UTR) adjacent to Gam for increasing homologous recombination.
MATERIALS AND METHODS

Construction of Plasmids Supplying Redα, Redβ, and Gam Proteins
We constructed plasmid pBADTc by replacing the ampicillin resistance gene of pBAD/HisA (Invitrogen, Carlsbad, CA, USA) with the tetracycline resistance gene of pTRG (Stratagene, La Jolla, CA, USA). Oligomers (5′-CCAAGCTTCGCGACTAGTTTA-AACCTGCAGGCGGCCGCTCAG-GTCGAGGTGGCCCGGCTCCAT-3′ and 5′-GGAAGCTTCATGTTTGAC-AGCTTATCATCG-3′) were used for the PCR amplification of the tetracycline resistance gene. The resulting PCR product was digested with HindIII and blunted. We ligated the DNA fragment onto the blunted BspHI fragment of pBAD/HisA. For the construction of pBADTcRed4, we used upstream primer 3 (5′-CGCCAT-G G ATAT TA ATA C T G A A A C T-GAGATC-3′) and downstream primer 4 (5′-CCAAGCTTCATCGCCATT-GCTCCCCAAATAC-3′) to PCR amplify the Gam-Redβ-Redα operon from the λ phage cIind ts857 Sam7 DNA (Invitrogen). The resulting PCR product was digested with NcoI and HindIII, and then ligated into the NcoI-HindIII site of pBADTc. For the construction of pBADTcRed19, we used another upstream primer, primer 5′-CGTCGACGCTTATA-AAAAATGG-3′, for PCR amplification. The resulting PCR product was inserted into the pGEM ® -T Easy Vector (Promega, Madison, WI, USA). The plasmid was digested with NcoI and SacI, and the NcoI-SacI DNA fragment was ligated into the NcoI-SacI site of pBADTc.
Preparation of the neo/km Cassette
Plasmid pMC1neoPolyA (Stratagene), which is often used for homologous recombination in mouse ES cells, contains the eukaryotic tk promoter and the neomycin resistance gene. The E. coli consensus promoter [-35 (TTGACA) and -10 (TATAAT)] was added upstream to the tk promoter of pMC1neoPolyA. The ShineDalgarno (SD)-kozak sequence 5′-AGGAGGCCACC-3′ was positioned in front of the ATG initiation codon. The modified neo gene works well in both E. coli and mouse ES cells. We positioned two 52-bp sequences homologous to the gene of interest, site A (5′-AGAAAGGCCAACGCT-GGGGGTCTCTGGAGCGCCGT-GGGATGCAAGCTATGGA-3′) and site B (5′-GGAGGATGAGCGGCTG-GCCAGTGCCCAGCAAGCAGAAG-TATTCACCAAGCAG-3′), at each end of the neo gene. Two BseRI sites were placed at each end of the neo/km cassette to facilitate the removal of the cassette from the plasmid. The neo/km cassette containing sites A and B was removed by digesting the plasmid with restriction endonuclease BseRI. Because the recognition site of BseRI is GAGGAG(10/8), a nonpalindromic sequence, and because BseRI cleaves at a distance from its recognition site, the resulting neo/km cassette had no nucleotide overhangs that might inhibit Red recombination. After digestion with BseRI, we recovered the neo/km cassette following agarose gel electrophoresis and purified it using the Wizard ® SV Gel and PCR Clean-Up System (Promega). The neo/km cassette was extracted with phenol/chloroform, precipitated with ethanol, and dissolved in TE (Tris-EDTA) buffer.
SDS-PAGE Analysis of Red Proteins
E. coli DH10B strain (Invitrogen) was transformed with either pBADTcRed4 or pBADTcRed4 derivatives. Transformants were grown on Luria-Bertani (LB) agar plates containing tetracycline (12.5 µg/mL). The cultures were grown overnight from a single colony, diluted 100-fold in 2 mL LB medium containing tetracycline (12.5 µg/mL), and then grown for 1.5 h to an A 600 of 0.1. Twenty microliters of 10% L-arabinose (final concentration of 0.1%) were added to 2 mL culture to induce Redα, Redβ, and Gam expression. The culture was incubated at 37°C for 2 h under gentle agitation. E. coli cells were centrifuged for 30 s at 14,000× g at 4°C, washed with 1 mL ice-cold phosphate-buffered saline (PBS), and resuspended in 300 µL PBS. These cells were subsequently lysed with a sonicator and centrifuged, and aliquots of soluble fractions were loaded onto 12.5% polyacrylamide gels and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The gels were stained with Coomassie ® brilliant blue (Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Red Recombination
E. coli DH10B strain (Invitrogen) containing a BAC of interest was transformed with either pBADTcRed4 or pBADTcRed4 derivatives by electroporation, according to a standard procedure (11) . Transformants were grown on LB agar plates containing tetracycline and chloramphenicol (12.5 µg/mL each). For BAC modification, cultures containing BACs were grown overnight from a single colony, diluted 100-fold in 2 mL LB medium containing tetracycline and chloramphenicol (12.5 µg/mL each), and then grown for 1.5 h to an A 600 of 0.1. We added 2 mL culture to 20 µL of 10% L-arabinose (final concentration of 0.1%) to induce Redα, Redβ, and Gam expression. The culture was incubated at 37°C for 1 h under gentle agitation. When an A 600 0.4 confluency of E. coli cells was achieved, they were centrifuged for 30 s at 8000× g at 2°C, washed gently with 1 mL ice-cold sterile water and 1 mL ice-cold sterile 10% glycerol twice, and resuspended in 25 µL ice-cold sterile 10% glycerol. Ice-cold competent cells (25 µL) and linear neo/km DNA cassettes (250 ng) were combined into 0.1 cm cuvettes, and cell transformation was performed by electroporation using a Gene Pulser ® II (Bio-Rad Laboratories, Hercules, CA, USA) set at 1.8 kV and at 25 µF with a pulse controller set to 200 ohms. One milliliter of SOC medium (Invitrogen) was added to the culture after electroporation. Following incubation at 37°C for 80 min under gentle agitation, the cells were spread onto LB agar plates containing kanamycin (25 µg/mL) and chloramphenicol (12.5 µg/mL), incubated for an additional 16 h, and drug-resistant colonies were counted. The recombination efficiency of the Red system was calculated by averaging the total number of surviving colonies in three independent experiments. Recombination was confirmed in 10-20 clones by using PCR with primers of BAC clone sequences located outside the identical A and B regions (Figure 1 ). These analyses revealed that over 95% of the clones correctly recombined.
Random PCR Mutagenesis and Screening of Clones Displaying a High Rate of Red Recombination Activity
We performed PCR-based random mutagenesis using primers 3 and 4 according to a method previously described (12) . For screening mutant Redα, the mutagenized PCR product was digested with EcoRI and HindIII and ligated into the EcoRI-HindIII site of pBADTcRed4. The ligated sample was transformed into E. coli DH10B, and then grown on LB plates containing 12.5 µg/mL tetracycline. Tetracycline-resistant colonies were pooled, and the plasmids were purified with a High-Purity Plasmid Midiprep System (Marlingen Bioscience, Ijamsville, MD, USA). The purified plasmid library was transformed into E. coli DH10B containing the BAC clone. Tetracycline-and chloramphenicol-resistant colonies were pooled and grown. We then performed the Red recombination reaction using the neo/km cassette. The plasmid from kanamycin-, chloramphenicol-, and tetracycline-resistant colonies had Red recombination activity. We carried out a second cycle of screening to concentrate plasmids with high rates of Red recombination. After the first cycle, kanamycin-, chloramphenicol-, and tetracycline-resistant colonies were pooled, inoculated, and grown in LB medium containing 12.5 µg/mL tetracycline. Purified plasmids were separated by agarose gel electrophoresis. We recovered plasmids that excluded the modified BAC clones harboring the neo/km cassette. Purified plasmids were subsequently transformed into E. coli DH10B containing the original BAC clone. Tetracyclineand chloramphenicol-resistant colonies were pooled, grown, combined with the neo/km cassette, and then Red recom- For screening mutant Redβ, the mutagenized PCR product was digested with SalI and EcoRI and ligated into the SalI-EcoRI site of pBADTcRed4. The same steps described above were repeated.
RESULTS
Because our BAC clone had an F factor origin, we chose a compatible, high copy number plasmid system, pBAD/HisA, as the backbone to supply the Red and Gam proteins required for homologous recombination. We did not choose the pSC101 plasmid because it is incompatible with a BAC clone and is a low copy number plasmid. Furthermore, we preferred the Red recombination system in a high copy number plasmid to that of an integrated form in the E. coli chromosome because it is more convenient and simpler to manipulate each component of the Red recombination system using a high copy number plasmid system.
To construct our gene targeting vector using this Red recombination system, we planned to introduce two cassettes, one containing the neo gene (for neomycin selection) and one containing the tk gene (for negative selection), into an intact BAC clone. This requires the use of two independent antibiotic selection markers. Initially, when Red recombination was performed using the tetracycline resistance gene as a selection marker, we encountered a significantly lower number of surviving colonies after recombination than when using kanamycin and ampicillin resistance genes. To increase the total number of surviving colonies after recombination, we constructed a new plasmid vector, pBADTc, from pBAD/HisA by replacing the ampicillin resistance gene with the tetracycline resistance gene. Steele et al. (13) observed an approximate 100-fold reduction in the transformation efficiency of E. coli using pBR322 when induced by electroporation but not by CaCl 2 , following selection with tetracycline rather than ampicillin. We concluded the same effect may be influencing our systemthe low number of surviving colonies after recombination that we initially observed may have occurred because of the low electroporation rates that occur with substrates containing the tetracycline resistance gene as the selectable marker. Using a similar approach to that used by Muyrers et al. (6), we constructed a vector capable of expressing the two Red gene products and the Gam gene product of λ phage. We inserted the gam, bet, and exo genes, in this order, into pBADTc in the form of an operon located between the ATG initiation codon and the transcriptional terminator of rrnB ( Figure 1 ). As with pBAD/HisA, pBADTc can be induced to express foreign gene products by treating cells with arabinose. A neo/km cassette contains neomycin and kanamycin resistance genes directed by both prokaryotic and eukaryotic promoters. This cassette also contains 52 bp DNA sequences (sites A and B) that are identical to the sequences of targeted sites of a gene in the BAC clone (Figure 1) . After inducing expression of the Red gene products with arabinose, we performed Red recombination by introducing the neo/km cassette into E. coli containing the BAC clone. We recovered approximately 20 colonies using both kanamycin and chloramphenicol selection plates (the BAC vector confers chloramphenicol resistance; the recombined BAC confers both kanamycin and chloramphenicol resistance). Detailed analysis revealed that these colonies recombined exactly at the expected target site. However, the rate of recombination was too low to warrant the use of this technique for routine modification of BAC clones. DNA sequencing of pBADTcRed4 confirmed that the gam, bet, and exo genes of λ phage inserted correctly. Moreover, no mutations were detected in pBADTcRed4. SDS-PAGE assessment for Red gene expression detected large amounts of Redα and Redβ proteins but no Gam protein after induction with arabinose ( Figure  2) ; these proteins were not observed before induction (data not shown), indicating that either Gam is a small protein and/or a small quantity of Gam was expressed (Figure 2) . Nonetheless, this finding indicated that there was a possible problem in the expression of Gam protein by pBADTcRed4.
Generally, when constructing expression vectors for efficient translation, a functional ribosome binding site containing an SD sequence is positioned 5′ to the ATG initiation codon (14) . The typical SD sequence is AGGAGG. Placing the SD and ATG initiation codon 9 ± 3 nucleotides apart increases translation. In pBADTcRed4, the SD sequence of Gam protein, AGGAGG, is located 8 bp upstream of the ATG initiation codon. Although we initially expected the SD translational signal to produce sufficiently high levels of Red gene products in E. coli, the lack of Gam protein production from pBADTcRed4 led us to conclude that some innate translational signal in the 5′ untranslated sequence used by wild-type λ phage may be necessary for Gam protein production. This prompted us to add an 18-bp 5′-UTR fragment to pBADTc. The 18-bp 5′-UTR plus Gam, Redβ, and Redα were derived from PCR reamplification using λ phage DNA as a template. Because PCR amplification may have induced mutations in the λ phage DNA that could affect recombination, we also assessed the recombination efficiency of six additional clones using the same neo/km cassette and E. coli containing the BAC clone. The pBADTcRed19 clone showed the highest rate of recombination of the Red system, recombining at a rate approximately 100 times higher than that of pBADTcRed4 ( Figure 3C ). However, the recombination efficiency of the five other clones was lower, which suggests that other factor(s) influenced the rate of recombination in pBADTcRed19. DNA sequencing revealed that, unlike pBADTcRed4, pBADTcRed19 contained two mutations in addition to the presence of the 18-bp 5′-UTR. One mutation occurred in the Redα stop codon, causing an insertion of an additional 48 amino acids (RRILITSEFA AACRSTIWES SRSAAGTIWE FEAWLFWRMR EDFQPDTD) at the carboxyl terminus of the Redα protein. The other mutation occurred in Redβ, resulting in a nonsynonymous amino acid substitution (Cys-to-Arg at position 118, C118R) in the Redβ protein ( Figure 3 ). These data provide the first evidence that mutations in Redα and Redβ proteins can increase the recombination efficiency of Red recombination. Thus, to determine which of the two mutations and/or 18 bp of 5′-UTR contributes most to increasing recombination efficiency, we constructed chimeric clones containing various combinations of these mutations and 18 bp 5′-UTR ( Figure 3B ).
For TypeA and TypeB clones, which contain either mutant Redα protein or mutant Redβ, respectively, recombination efficiency increased approximately 2-fold. For the TypeC clone, which contains both mutant Redα and Redβ proteins, efficiency increased approximately 4-fold, indicating that, because of this additive effect, mutant Figure  1 ), we assessed 10-20 clones and confirmed that over 95% of these clones correctly recombined. UTR, untranslated region; SD, Shine-Dalgarno; BAC, bacterial artificial chromosome. To determine how mutations in Redα and Redβ proteins affect the amounts of Red protein produced by E. coli after arabinose induction, we performed SDS-PAGE analysis of the Red protein produced from bacteria transformed with pBADTcRed19. Because Redα protein from pBADTcRed19 had an extra 48 amino acids, its size is expected to be 5.7 kDa larger than that of the intact Redα protein. Its expression levels, however, were undetectable for unknown reasons, perhaps because of instability of the Redα protein containing the extra 48 amino acids. The amount of Redα protein from pBADTcRed19 significantly decreased compared to the amount produced from pBADTcRed4. The amount of Redβ protein from pBADTcRed19, on the other hand, was almost that same as that from pBADTcRed4 ( Figure 2) .
These results suggest that other types of mutant Redα and Redβ proteins may also increase recombination efficiency significantly. To test whether this is indeed the case, we first constructed a clone library of mutant Redα and Redβ proteins using pBADTcRed4 and random PCR mutagenesis with dITP. We then screened for clones displaying high rates of recombination by transforming these mutant Red protein clones into E. coli harboring the BAC clone and performing the Red recombination reaction with the neo/km cassette. Next, we selected kanamycin-resistant colonies and concentrated mutant Redα and Redβ protein clones displaying efficient Red recombination by purification. Plasmids supplying the mutant Red proteins were reintroduced into E. coli containing the BAC clone, and we screened for clones displaying high rates of recombination by performing the Red recombination reaction again. Using this method of kanamycin resistance selection and two cycles of Red recombination, we were able to obtain an increasing number of clones that consistently displayed high rates of recombination. To assess the role of mutant Redα protein in promoting recombination, we sequenced these plasmids and identified three clones from the 10 colonies we tested that possessed a mutation in Redα resulting from a nonsynonymous amino acid substitution (R137Q; Figure 3C , TypeF). When Red recombination was performed using the TypeF plasmid, recombination efficiency increased 15-fold compared to that of pBADTcRed4 ( Figure 3C ). However, the recombination efficiency of the other clones was almost the same as that of pBADTcRed4. The recombination efficiency of clones possessing mutant Redβ protein remained unchanged, even when two cycles of Red recombination were performed.
SDS-PAGE revealed that TypeF produced nearly the same amount of mutant Redα protein (data not shown) as did pBADTcRed4 (Figure 2 ). This is in stark contrast to pBADTcRed19, which produced less mutant Redα protein than did pBADTcRed4. These findings suggest that the mechanism by which recombination increases is different in cells transformed with TypeF compared to those transformed with pBADTcRed19. Thus, because the Redα protein of pBADTcRed19 increased recombination 2-fold, whereas the Redα protein of TypeF increased recombination 15-fold, we expected a higher rate of Red recombination in systems using mutant Redα protein from TypeF than in systems using Redα protein from pBADTcRed19. As shown in Figure  3C , TypeG, which contains both mutant Redβ and Redα as well as 5′-UTR, increased recombination 1.2-fold compared to pBADTcRed19. Thus, the TypeG plasmid contains the combination of genes that promotes the most efficient Red recombination based on a high copy number plasmid.
DISCUSSION
Previous attempts to increase the efficiency of Red recombination mainly focused on changing the transcriptional promoter and copy number of expression units supplying Red proteins. This study is the first to report that mutant Redα and Redβ proteins increase the recombination efficiency of the Red recombination system. Mutant Redα (R137Q) and mutant Redβ (C118R) proteins increased the rate of recombination 2.5-fold (compare TypeD and TypeG plasmids) and 2-fold, respectively. In addition, we found that the 18-bp 5′-UTR of λ Gam also increases the rate of Red recombination. Modifying the translational control region of Gam by placing the 18-bp 5′-UTR from wild-type λ phage in front of the initiation ATG codon and the SD sequence 45 bp upstream of ATG ( Figure 3A) , we increased the efficiency of Red recombination in our high copy number plasmid system by 25-fold. The importance of the 5′-UTR of Gam protein in promoting Red recombination has not been previously reported.
At the present time, we do not know exactly how the 18-bp 5′-UTR from λ phage affects recombination efficiency. One possibility is that the λ 5′-UTR may increase recombination by decreasing Gam production. In pBADTcRed4, the typical SD sequence is optimally positioned upstream of ATG, thus ensuring the expression of sufficiently large amounts of Gam protein in E. coli harboring pBADTcRed4. We found recombination efficiency, however, to be greatly influenced by the viability of transformed E. coli, which in turn was influenced by Gam protein, which, in large amounts, is toxic to E. coli (15) . Indeed, E. coli harboring pBADTcRed4 displayed slow growth rates (data not shown) and decreased recombination rates, which indicates that enough Gam was translated from pBADTcRed4 to affect, to some degree, E. coli viability and to decrease recombination. In contrast, E. coli harboring pBADTcRed19, a clone containing λ 5′-UTR, displayed normal growth rates (data not shown) and increased recombination rates. We believe that the 18-bp 5′-UTR decreases Gam protein translation in E. coli by means of a λ phage SD sequence, thus maintaining Gam production at sufficiently low levels, while preserving host viability and increasing recombination efficiency. The 18-bp 5′-UTR sequence from λ phage did not contain the typical SD sequence. This would explain why the recombination efficiency of pBADTcRed19 was high and that of pBADTcRed4 was low. At present, we have little information about the mechanism underlying the increased recombination efficiency caused by mutant Redα and Redβ proteins because substitutions identified in this study are not located in any previously characterized functional domains of Redα and Redβ proteins (16) . An alternative interpretation of our findings is that both Redα mutations lower Redα activity relative to Redβ activity. Indeed, when two Red proteins are expressed separately under the direction of promoters with different strengths, Muyrers and coworkers (7) observed that increasing the Redβ/RecT-to-Redα/RecE ratio increased the efficiency of Red/ET (RecE/RecT) recombination (7) .
For the present study, we used a high copy number plasmid system because this system offers some advantages. When screening for mutants, as described here in this report, clone manipulation and identification by DNA sequencing become easier and more convenient when using high copy number plasmids because these plasmids result in higher yields. Another positive aspect of using high copy number plasmids is that many scientists, not just specialists accustomed to using plasmid systems, can easily adopt this method with a minimum of technical pitfalls compared to other methods that use unusual expression systems. During the preparation of our manuscript, pSC101-BAD-gbaA tetra , a plasmid developed previously for BAC modification, became commercially available throughout the world. This system uses pSC101, a low copy number plasmid, for supplying the two Red proteins and Gam protein for recombination (8) . One potential problem with using pSC101-BAD-gbaA tetra to modify BACs is maintaining plasmid stability because both pSC101 and BACs (F factor origin) belong to the same incompatibility group (11) . Using the pSC101-BAD-gbaA tetra system with our BAC clone and neo/km cassette according to the manufacturer's procedure, we were able to recover approximately 250 competent colonies (data not shown). Although the recombination efficiency of the pSC101-BAD-gbaA tetra system does not preclude practical modification of BAC clones, its efficiency is lower than that of our system. In addition, the long-term effects of using pSC101 and BACs belonging to the same incompatibility group remain unknown.
In conclusion, we were able to make BAC modifications more easily with our high copy number plasmid system than with standard techniques. By using compatible BAC clones and pBR322-derived plasmids for introducing Red proteins into E. coli, we can simultaneously screen BACs of interest from a BAC library and modify these BACs for the construction of targeting vectors needed to prepare gene-targeted mice. At present, these two steps, screening BACs of mouse genomic DNA containing a gene of interest and constructing targeting vectors, are routinely performed separately. Because mouse genomic sequences available at public databases are now very accurate, we can now design two 50-60 base segments directly from these databases for the Red recombination system. In a single Red recombination reaction, one can simultaneously screen the BAC library and modify the BAC clone by introducing a neo/km cassette into a targeted region of the gene of interest. Currently, many groups, including our own, screen BAC clones using 96-or 384-well plates and PCR amplification, which is a tedious, multistep task. It is especially very difficult to obtain a sufficient number of plates (with BAC clones contained within each of the 384 wells) for the initial step of this procedure. On the other hand, it is very easy to obtain a sufficient number of pooled samples from agar plates where thousands of BAC colonies can be grown. Using PCR, we can identify which pool contains the BAC clone of interest, and with one Red recombination reaction, we can simultaneously screen the BAC and modify it. The success of our preliminary experiments demonstrates that this strategy promises to be a more high-throughput method compared to previous methods. Finally, our novel finding that mutant Red proteins increase recombination efficiency can serve as the impetus for the systematic and large-scale screening of other potential mutants that can promote efficient recombination.
